30 April 2020

Warning & Withdrawals of Health-related Products

Reference: CIR-2019-00000289

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

• Warning regarding using pharmaceutical product
• Recall & Suspension of registration of pharmaceutical product Gupisone Syrup
• Recall specific batch’s of medical device BD Microtainer K2E tubes
• Safety alerts from using the Nutritional supplements Passion Classic Maximum Power, Red Lips Premium Triple Maximum
• Withdrawal of the complaint concerning medical device
• Safety update of pharmaceutical product Blincyto (Blinatumomab)

  

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Warning regarding using pharmaceutical product.pdf:

View Document

pot. chloride MHRA.pdf:

View Document

Recall _ Suspension of registration of pharmaceutical product Gupisone Syrup.pdf:

View Document

Recall specific batchs of medical device BD Microtainer K2E tubes.pdf:

View Document

Safety alerts from using the Nutritional supplements Passion Classic Maximum Power Red Lips Premium Triple Maximum.pdf:

View Document

Withdrawal of the complaint concerning medical device.pdf:

View Document

Safety update of pharmaceutical product Blincyto (Blinatumomab).pdf:

View Document